Low-Dose Yellow Fever Vaccine in Adults in Africa
Kimathi D. et al, (2025), New England Journal of Medicine, 392, 788 - 797
Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study
Kimotho J. et al, (2024), Wellcome Open Research, 8, 350 - 350
Identification of complex Plasmodium falciparum genetic backgrounds circulating in Africa: a multicountry genomic epidemiology analysis.
Miotto O. et al, (2024), The Lancet. Microbe
Prospective clinical surveillance for severe acute respiratory illness and COVID-19 vaccine effectiveness in Kenyan hospitals during the COVID-19 pandemic.
Lucinde RK. et al, (2024), BMC infectious diseases, 24
Effects of the COVID-19 pandemic on hospital admissions and inpatient mortality in Kenya: a retrospective cohort study
Ogero MO. et al, (2024), Wellcome Open Research, 9, 582 - 582
Antibodies to PfEMP1 and variant surface antigens: Protection after controlled human malaria infection in semi-immune Kenyan adults.
Kinyua AW. et al, (2024), The Journal of infection, 89
A retrospective analysis of P. falciparum drug resistance markers detects an early (2016/17) high prevalence of the k13 C469Y mutation in asymptomatic infections in Northern Uganda.
Ogwang R. et al, (2024), Antimicrobial agents and chemotherapy, 68
The mRNA content of plasma extracellular vesicles provides a window into molecular processes in the brain during cerebral malaria
Kioko M. et al, (2024), Science Advances, 10
Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.
Rosenkranz M. et al, (2024), Life science alliance, 7
Linking Cerebral Malaria Pathogenesis to APOE-Mediated Amyloidosis: Observations and Hypothesis.
Kioko M. et al, (2024), Molecular neurobiology
Comparative performance of the InBios SCoV-2 DetectTM IgG ELISA and the in-house KWTRP ELISA in detecting SARS-CoV-2 spike IgG antibodies in Kenyan populations
Kutima B. et al, (2024), Wellcome Open Research, 9, 349 - 349
Utility of MALDI-TOF MS for determination of species identity and blood meal sources of primary malaria vectors on the Kenyan coast
Karisa J. et al, (2024), Wellcome Open Research, 8, 151 - 151
Breadth of Fc-mediated effector function correlates with clinical immunity following human malaria challenge.
Nkumama IN. et al, (2024), Immunity, 57, 1215 - 1224.e6
Tungiasis among children in Kenya is associated with poor nutrition status, absenteeism, poor school performance and high impact on quality of life
Elson L. et al, (2024), PLOS Neglected Tropical Diseases, 18, e0011800 - e0011800
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial
Datoo MS. et al, (2024), The Lancet, 403, 533 - 544
Age-dependent acquisition of IgG antibodies to Shigella serotypes-a retrospective analysis of seroprevalence in Kenyan children with implications for infant vaccination.
Kapulu MC. et al, (2024), Frontiers in immunology, 15
Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against Plasmodium falciparum parasites.
Ogwang R. et al, (2024), Frontiers in immunology, 15
Distinct transcriptomic signatures define febrile malaria depending on initial infective states, asymptomatic or uninfected.
Kimenyi KM. et al, (2024), BMC infectious diseases, 24
Antibody responses to recombinant vesicular stomatitis virus-Zaire Ebolavirus vaccination for Ebola virus disease across doses and continents: 5-year durability.
Huttner A. et al, (2023), Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 29, 1587 - 1594